Malaria Vaccines Are Showing Real-World Results: What Comes Next?
Evidence from African countries using malaria vaccines suggests that vaccination can prevent child deaths, but vaccines must be combined with other malaria-control tools.
malaria vaccine child / health worker
What happened?
Evidence from African countries using malaria vaccines suggests that vaccination can prevent child deaths, but vaccines must be combined with other malaria-control tools. WHO reports that malaria caused an estimated 282 million cases and 610,000 deaths globally in 2024.
Key points
- WHO reports that malaria caused an estimated 282 million cases and 610,000 deaths globally in 2024.
- The WHO African Region accounted for the overwhelming majority of global malaria cases and deaths.
- A four-year evaluation of RTS,S vaccine use in Ghana, Kenya and Malawi estimated that one in eight child deaths among eligible children were averted.
- WHO recommends malaria vaccination for children living in malaria-endemic areas, especially where transmission is moderate or high.
- Vaccination is part of a wider package that includes mosquito nets, diagnosis, treatment and other prevention measures.
What we know
- WHO reports that malaria caused an estimated 282 million cases and 610,000 deaths globally in 2024.
- The WHO African Region accounted for the overwhelming majority of global malaria cases and deaths.
- A four-year evaluation of RTS,S vaccine use in Ghana, Kenya and Malawi estimated that one in eight child deaths among eligible children were averted.
- WHO recommends malaria vaccination for children living in malaria-endemic areas, especially where transmission is moderate or high.
- Vaccination is part of a wider package that includes mosquito nets, diagnosis, treatment and other prevention measures.
What officials/people involved say
WHO describes the real-world evidence as a significant confirmation of vaccine impact while stressing that malaria control requires multiple interventions.
Background
Malaria is caused by parasites transmitted through infected mosquitoes. The burden is heavily concentrated in Africa, where young children are at greatest risk of severe disease and death. The arrival of two WHO-recommended vaccines has created a new prevention tool alongside long-established methods.
Why it matters
The significance is not simply the existence of a vaccine. It is the possibility of combining vaccination with other interventions in places where health systems already carry a heavy malaria burden. Delivery, financing, cold-chain logistics and community confidence will influence the real-world effect.
What happens next?
Countries will continue expanding vaccine programmes while monitoring impact and coverage. Researchers are also developing additional malaria vaccines and other technologies. The strongest strategy remains layered prevention rather than relying on a single tool.
Sources & further reading
Every claim above can be traced to the documents below.
Author
Insight Media Editorial Desk — original reporting, explainers, analysis and practical guides, researched against primary documents and credible independent reporting. Developing stories are updated when significant new verified information becomes available.